Route 92 Stock
HealthTechLooking to sell Route 92 stock or options?
Route 92 is the developer of an innovative medical device aimed at treating strokes and similar conditions. Their device features a percutaneous catheter for addressing acute ischemic stroke, a rapid aspiration thrombectomy system, and a delivery system for intra-cerebral implants. This technology empowers healthcare professionals to effectively treat patients and enhance the recovery process for those overcoming a stroke.
Investors Include:
Runway Growth Capital, Novo Holdings, Norwest Venture Partners, U.S. Venture Partners, The Vertical Group, InnovaHealth Partners.